FOXA1 and neoplasm: In the xenograft model, the co-knockdown of FOXA1 and BMI1 in CNE1 cells resulted in an increased sensitivity to cisplatin, as indicated by reduced tumor size (Fig. 6F, H) and decelerated growth rates (Fig. 6G), in stark comparison to the FOXA1-knockdown cells that displayed resistance.